Urinary incontinence Clinical Trials in Rochester, NY
As of June 2026, 1 paid clinical trial is recruiting for Urinary incontinence in Rochester, New York. Recruiting Urinary incontinence studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Related specialties in Rochester
Filter results
1 clinical trial for Urinary incontinence
·Clear filters·↓ Download CSVAbout research studies in Rochester
Rochester has approximately 500 recruiting research studies across a wide range of therapeutic areas. New York is home to leading academic medical centers such as Memorial Sloan Kettering, Weill Cornell Medicine, Mount Sinai, NYU Langone, and Columbia University Irving Medical Center. These institutions anchor a research ecosystem that covers oncology, cardiology, neurology, and rare disease.
Top Research Study Locations in Rochester
Researchers run research studies in Rochester, NY at 25 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| University of Rochester | Acute Myeloid Leukemia, Stage IV Lung Cancer AJCC v8, Breast Cancer | 188 |
| University of Rochester Medical Center | Healthy, Atopic Dermatitis, Breathing | 110 |
| Highland Hospital | Stage IVA Prostate Cancer AJCC v8, Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8 | 16 |
| Rochester General Hospital | Aortic Valve Stenosis, Acute Myeloid Leukemia, Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm | 13 |
| Rochester Clinical Research, LLC | Obesity, Overweight, Atherosclerotic Cardiovascular Disease (ASCVD) | 10 |
| Pluta Cancer Center | Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8 | 9 |
| Wilmot Cancer Institute Radiation Oncology at Greece | Stage IV Lung Cancer AJCC v8, Advanced Colorectal Carcinoma, Advanced Lung Non-Small Cell Carcinoma | 8 |
| Wilmot Cancer Institute | Acute Leukemia, Aplastic Anemia, Breast Cancer | 6 |
| Strong Memorial Hospital | Aortic Stenosis, Atrial Fibrillation, Cardiotoxicity | 5 |
| University of Rochester Medical Center (URMC) | Adult Acute Myeloid Leukemia, Hpv, Phenylketonuria | 5 |
| Retina Associates of Western NY, P.C. | Diabetic Retinopathy, Epiretinal Membrane, Neovascular Age-related Macular Degeneration | 4 |
| Rochester Clinical Research | Atherosclerotic Cardiovascular Disease, Crohn's Disease, Influenza | 4 |
| GSK Investigational Site | Gastrointestinal Neoplasms, Tumours, Gynecological, Urinary Tract Infections | 3 |
| Unity Park Ridge Campus | Muscle Invasive Bladder Urothelial Carcinoma, Muscle Invasive Renal Pelvis Urothelial Carcinoma, Muscle Invasive Ureter Urothelial Carcinoma | 3 |
| University of Rochester Medical Center- Site Number : 840105 | Cerebroside Lipidosis Syndrome, Fabry Disease, Gaucher Disease | 3 |
| University of Rochester Wilmot Cancer Institute | Angiosarcoma, Breast Cancer, Breast Neoplasms | 3 |
| AD-CARE, University of Rochester Medical Center | Alzheimers Disease | 2 |
| Akero Clinical Study Site | MASH - Metabolic Dysfunction-Associated Steatohepatitis, MASH With Fibrosis, NASH - Nonalcoholic Steatohepatitis | 2 |
| American Thrombosis and Hemostasis Network | Bleeding Disorder, Connective Tissue Disorder, Factor IX Deficiency | 2 |
| Finger Lakes Clinical Research | Alzheimer's Disease Psychosis, Pediatric Migraine | 2 |
| Gastroenterology Group Of Rochester, LLP | Moderately to Severely Active Crohns Disease, Moderately to Severely Active Ulcerative Colitis | 2 |
| Gastroenterology Group of Rochester | Colonic Polyps, Crohn's Disease, Ulcerative Colitis | 2 |
| Mayo Clinic | Lymphedema, Breast Cancer, Solid and Hematological Malignancies | 2 |
| Mt. Hope Family Center | Fetal Alcohol Spectrum Disorders, Posttraumatic Stress Disorder | 2 |
| Retina Associates of Western New York | Age Related Macular Degeneration (AMD), DME, Diabetic Macular Edema | 2 |
Active & Upcoming Studies in Rochester (2026)
Recruiting trials in Rochester grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (186 active studies)
- Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates · Phase 2 · University of Colorado, Denver
- Study of Perioperative NP137 and FOLFIRINOX in Resectable Pancreatic Cancer · Phase 1 · Aram Hezel
Neurology & pain (30 active studies)
- Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression · Phase 2 · University of Rochester
- Tele-Savvy for Latino Caregivers · University of Rochester
Cardiovascular (21 active studies)
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
- Comparative Effectiveness of Different Techniques for Repeat Ablation of Atrial Fibrillation · University of Rochester
Diabetes & metabolic (15 active studies)
- A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight · Phase 2 · Eli Lilly and Company
- A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity · Phase 3 · Novo Nordisk A/S
Eye & vision (12 active studies)
- BriTer Eyez Moisture Vue™ On-Demand Disposable Moisture Chamber · University of Rochester
- COMO: A Phase 3 Randomized, Double-Masked Study Comparing the Efficacy of EYP-1901 Against Aflibercept in DME · Phase 3 · EyePoint Pharmaceuticals, Inc.
Mental health & behavior (11 active studies)
- Ketamine-Assisted Psychotherapy for Treatment-Resistant Depression · Phase 2 · University of Rochester
- Deaf CBT-TS to Reduce Suicide Risk · University of Rochester
Pediatric (8 active studies)
- Tumor-Lymph Node Mapping · University of Rochester
- Multiphase Optimization Strategy (MOST) for Treating Pediatric Post-traumatic Stress Disorder (PTSD) · University of Rochester
HIV / STI (4 active studies)
- Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV · Phase 2 · National Institute of Allergy and Infectious Diseases (NIAID)
- Clinical Trial to Evaluate the Safety and Immunogenicity of the V2 Apex-Directed Immunogens DV201P-RNA and DV202B1-RNA in Adult Participants Without HIV · Phase 1 · National Institute of Allergy and Infectious Diseases (NIAID)
Vaccines (3 active studies)
- SAVE: School Ambassadors for Vaccine Education · University of Rochester
- A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure · Phase 2 · Tarsus Pharmaceuticals, Inc.
Common conditions studied in Rochester
- Acute Myeloid Leukemia (12 active studies). Leukemia trials evaluate targeted inhibitors, CAR-T cell therapies, and novel combinations for acute and chronic forms of the disease.
- Breast Cancer (10 active studies). Breast cancer trials evaluate new hormone therapies, targeted drugs, and immunotherapy combinations aimed at improving survival and reducing recurrence.
- Cancer (7 active studies). Recruiting Cancer studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Obesity (7 active studies). Obesity trials evaluate GLP-1 and GIP receptor agonists, novel metabolic drugs, and combined lifestyle interventions for sustainable weight loss.
- Prostate Cancer (7 active studies). Prostate cancer studies test next-generation hormone therapies, PARP inhibitors, and radioligand treatments for both localized and advanced disease.
- Stage IV Lung Cancer AJCC v8 (7 active studies). Lung cancer research focuses on targeted therapies for specific mutations such as EGFR, ALK, and KRAS, alongside immunotherapy regimens.
Leading research sponsors in Rochester
- University of Rochester
- National Cancer Institute (NCI)
- SWOG Cancer Research Network
- Children's Oncology Group
- Eli Lilly and Company
Local regulations and guidelines
Clinical trials in New York are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Trials conducted in New York must also comply with the NY SHIELD Act's data-protection requirements and additional oversight from the New York State Department of Health.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Rochester. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Rochester
Hipa.ai aggregates every recruiting study in Rochester from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Rochester?
There are approximately 500 recruiting clinical trials in Rochester, New York listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Rochester pay participants?
Most recruiting trials in Rochester compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Rochester?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Rochester?
The most common conditions under active study in Rochester include Acute Myeloid Leukemia (12), Breast Cancer (10), Cancer (7), Obesity (7), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Rochester?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Rochester on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Rochester?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Rochester?
Recruiting research sites in Rochester include University of Rochester, University of Rochester Medical Center, Highland Hospital, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Rochester right now?
The largest active categories in Rochester are Cancer & tumors (186), Neurology & pain (30), Cardiovascular (21). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.